glp-1 receptor agonists weight loss Medications: Everything You Need to Know Glucagon-like peptide-1 receptor agonists (GLP-1RAs)

SGLT-2 inhibitors act primarily in the renal proximal tubule and have no established direct actions on mesolimbic reward circuits in the brain.63 On the contrary, neurotropism is a distinct property of GLP-1 receptor agonists.62 GLP-1 is produced in the brain, GLP-1 receptors are present in areas of the brain involved in impulse control and reward signalling, and a pharmacologically administered exogenous GLP-1 receptor agonist crosses the blood-brain barrier and enters the brain within minutes, strengthening the inference that the observed GLP-1 receptor agonist anti-addictive properties are likely specific and biologically plausible drug effect of GLP-1 receptor agonism, distinct from the general benefits of treating diabetes that would be expected with both SGLT-2 inhibitors and GLP-1 receptor agonists.6465 These observational findings do not by themselves justify the prescribing of GLP-1 receptor agonists specifically to prevent or treat SUDs

doi: 10.3390/diseases12010014 45 DruckerDJ

GLP-1 medications are also called: Glucagon-like peptide-1 agonists GLP-1 agonists Incretin mimetics They influence different organs throughout the body, including: Brain Pancreas Stomach Liver Heart GLP-1s work by producing a synthetic version of a hormone released in the intestine when we eat - helping to regulate food intake and better control glucose

Individuals should be screened for signs of eating disorders (binge eating, anorexia nervosa, bulimia nervosa, night eating)

The separate MDL structure reflects the different medical evidence, expert testimony, causation issues, and injury mechanisms involved in NAION claims compared to gastroparesis, bowel obstruction, and other gastrointestinal injury cases